| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00401-017-1669-Y |
| P698 | PubMed publication ID | 28130638 |
| P50 | author | Yili Wu | Q56391082 |
| Weihong Song | Q42153702 | ||
| P2093 | author name string | Li Chen | |
| Jie Chen | |||
| Zhe Wang | |||
| Qian Chen | |||
| Tingyu Li | |||
| Zhen Fan | |||
| Lan Ren | |||
| Hongpeng Jiang | |||
| Jiaying Zeng | |||
| P2860 | cites work | Vitamin A: biomarkers of nutrition for development | Q24629945 |
| Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients | Q24633400 | ||
| Maternal and child undernutrition: consequences for adult health and human capital | Q24642106 | ||
| Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction | Q28181660 | ||
| Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo | Q43051937 | ||
| Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease | Q44060098 | ||
| Marginal vitamin A deficiency affects lung maturation in rats from prenatal to adult stage | Q44440079 | ||
| Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. | Q44555815 | ||
| BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease | Q44722202 | ||
| Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain | Q45014651 | ||
| Vitamin A deficiency impairs postnatal cognitive function via inhibition of neuronal calcium excitability in hippocampus | Q45603529 | ||
| Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice | Q46143430 | ||
| Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats | Q46986299 | ||
| Increased gene expression of beta-amyloid precursor protein and its homologues APLP1 and APLP2 in human neuroblastoma cells in response to retinoic acid | Q48054926 | ||
| Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species | Q48390009 | ||
| Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease | Q48437807 | ||
| Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7. | Q48560260 | ||
| The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice | Q50746796 | ||
| Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis | Q50902089 | ||
| Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. | Q52608158 | ||
| Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin. | Q53358084 | ||
| Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein | Q28260479 | ||
| APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy | Q28288090 | ||
| Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective | Q29614702 | ||
| Maternal and child undernutrition and overweight in low-income and middle-income countries | Q29617926 | ||
| Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes | Q30530899 | ||
| Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease | Q30719950 | ||
| Retinoic acid restores adult hippocampal neurogenesis and reverses spatial memory deficit in vitamin A deprived rats. | Q33378488 | ||
| Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity | Q33944863 | ||
| Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling | Q34267967 | ||
| Global malnutrition | Q34270019 | ||
| Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis | Q34379154 | ||
| Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis | Q34554154 | ||
| Vitamin A supplementation in early life enhances the intestinal immune response of rats with gestational vitamin A deficiency by increasing the number of immune cells | Q34681947 | ||
| Evidence for defective retinoid transport and function in late onset Alzheimer's disease | Q34809021 | ||
| Fetal and placental size and risk of hypertension in adult life | Q35170031 | ||
| Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression | Q35214758 | ||
| Relationship between eating disturbance and dementia severity in patients with Alzheimer's disease | Q35743549 | ||
| All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor κB (NFκB) signaling | Q36049939 | ||
| Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows | Q36772052 | ||
| The role of microglia in amyloid clearance from the AD brain | Q36841789 | ||
| Retinoic acid in the development, regeneration and maintenance of the nervous system | Q36946560 | ||
| Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein | Q37025855 | ||
| Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage | Q37239146 | ||
| Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. | Q37352348 | ||
| Evidence for impaired amyloid β clearance in Alzheimer's disease | Q37690374 | ||
| The neurobehavioral teratology of retinoids: A 50‐year history | Q37791998 | ||
| Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) Processing. | Q39661608 | ||
| Regulation of secretases by all-trans-retinoic acid | Q39846093 | ||
| Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin | Q39895248 | ||
| Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models | Q39924456 | ||
| BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome | Q40260424 | ||
| Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription | Q40322589 | ||
| Increased processing of APLP2 and APP with concomitant formation of APP intracellular domains in BDNF and retinoic acid-differentiated human neuroblastoma cells | Q40376035 | ||
| Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes | Q40429845 | ||
| Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | Q40581861 | ||
| Regulation of β-amyloid precursor protein and inositol 1,4,5-trisphosphate receptor gene expression during differentiation of a human neuronal cell line | Q40656071 | ||
| Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist | Q40755303 | ||
| Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 | ||
| Leaky scanning and reinitiation regulate BACE1 gene expression | Q42091639 | ||
| P433 | issue | 6 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| vitamin A deficiency | Q2655893 | ||
| P304 | page(s) | 967-982 | |
| P577 | publication date | 2017-01-27 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis | |
| P478 | volume | 133 |
| Q60595360 | A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling |
| Q89960798 | Association of Circulating Retinol and α-TOH Levels with Cognitive Function in Aging Subject with Type 2 Diabetes Mellitus |
| Q60595359 | BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis |
| Q89683589 | Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention |
| Q42148788 | Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study. |
| Q47965428 | Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes |
| Q89879977 | Lipids and Alzheimer's Disease |
| Q41665323 | Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease |
| Q64860569 | Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation |
| Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
| Q91762131 | Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease |
| Q92510457 | The Synthetic Retinoid Acitretin Increases IL-6 in the Central Nervous System of Alzheimer Disease Model Mice and Human Patients |
| Q48095241 | The interaction of selenoprotein F (SELENOF) with retinol dehydrogenase 11 (RDH11) implied a role of SELENOF in vitamin A metabolism |
| Q47992068 | Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer's Disease in a Murine Model |
| Q64966903 | Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer's disease. |
| Q58725822 | Vitamin A Deficiency and the Lung |
| Q90738238 | Vitamin A deficiency increases the risk of gastrointestinal comorbidity and exacerbates core symptoms in children with autism spectrum disorder |
Search more.